A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

March 29, 2007

Green Tea for HIV?

by Tim Horn

A component of green tea blocks the ability of HIV to enter CD4 cells, according to the results of test tube studies reported by researchers at the University of Sheffield in the United Kingdom and Baylor College of Medicine in Houston. The encouraging research is published in a recent issue of the Journal of Allergy and Clinical Immunology.

Green tea is a nonoxidized, unfermented product of leaves from Camellia sinensis, an evergreen plant. It is made up of catechins, chiefly epigallocatechin gallate (EGCG), and has been credited with possessing health benefits, including cancer and cardiovascular disease prevention properties. Studies have also suggested that EGCG can prevent HIV from binding the CD4 cells, although the reason for this has remained a mystery.  

Using the tools of computational and structural biology, the University of Sheffield and Baylor College of Medicine researchers modeled the structure of the EGCG molecule to find the mechanism by which it prevents the HIV gp120 protein from binding to receptors on CD4 cells.

"We found that the EGCG molecule itself binds to the same exact binding pocket on the CD4 molecule at the site of the same amino acids to which gp120 binds," said Baylor's Christina Nance, MD, PhD. "When it binds there, the gp120 envelope protein, and thus HIV, can't."

According to Dr. Nance, the investigators were determined to show that physiological levels of EGCG – an amount achieved by drinking just two cups of green tea – caused inhibition of gp120 binding to CD4 cells. After all, artificially high concentrations of EGCG placed in test tubes to inhibit binding have no meaning for patients.

The test tube studies suggested that EGCG concentrations as low as 0.2 mmols/L – the amount of the molecule found in a cup or two of green tea – reduced HIV-CD4 cell binding by 40%. 

Today, Dr. Nance and her colleagues are trying to develop a three-dimensional replica of the molecule for a definitive determination of EGCG binding and inhibition of HIV. From that, researchers may be able to model synthetic molecules that might be even better at inhibiting HIV binding, or additives that could make the EGCG activity more sustainable.

EGCG has already been studied in cancer, Dr. Nance said. Those studies have shown it to be safe and non-toxic. However, its effect on immunological cells is not yet determined. Her group is currently doing studies of those effects in the laboratory at Texas Children's Hospital.

Dr. Nance does not recommend that people drink large quantities of green tea with the expectation that it will prevent infection with HIV. These studies, she said, were designed to determine whether a drug derived from green tea would have that effect. A Phase I/II clinical trial of EGCG is being planned.

Source:

Williamson MP, McCormick TG, Nance CL, Shearer WT, et al. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 118:1369-74, 2006.


[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    romanticseattle
    Tacoma
    Washington


    youngbloodlatino
    Columbia
    Maryland


    daino1972
    Columbus
    Ohio
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.